Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7274 p637
8 November 2003

This article
Reprint
Photocopy


News summary

Related websites
Annals of Internal Medicine abstract (more)


Osteoarthritis pain relieved by leeches

Leech therapy appears to improve the symptoms of osteoarthritis and could offer patients an alternative approach to pain relief, a new study reveals.

Researchers from the University of Duisburg-Essen in Germany decided to test their hypothesis that substances found in leech saliva might relieve osteoarthritic pain through their effects on inflammation. They assigned 51 patients with osteoarthritis of the knee to either leech therapy or treatment with diclofenac gel.

Patients in the leech therapy group had one treatment session during which four to six leeches were applied to the affected knee and left until they detached themselves. Patients in the diclofenac group were instructed to apply the gel to the affected knee at least twice a day for 28 days. Patients’ pain, stiffness and function were assessed by the researchers after three, seven, 28 and 91 days using standard questionnaires.

The researchers found that patients assigned to leech therapy reported less pain at day seven than patients who used diclofenac gel. They also reported less stiffness, better function and fewer total arthritic symptoms throughout the 91 days of the study, although both groups reported similar amounts of pain at 28 and 91 days.

The researchers suggest that the therapeutic effect of leeches in osteoarthritis may be due to salivary secretion of analgesic agents, such as inhibitors of kallikrein, as well as anti-inflammatory agents, including proteinase inhibitors. “Through the concomitant activity of a further leech saliva component, hyaluronidase, these substances might reach deeper tissue zones and possibly the joint space,” they say.

The researchers emphasise the preliminary nature of the trial (Annals of Internal Medicine 2003;139:724).

The author of an accompanying editorial suggests that future studies should consider the mechanism of action by which leech therapy might exert an analgesic effect. “The more exciting aspect of this work is the potential for the discovery of a novel analgesic agent that could be safely administered without the need for a leech bite,” he adds (ibid, p781).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal